Senolytic Therapeutics Companies
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Investors Number:
7
Total Funding:
583303
Technology:
AgeTech
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Industry:
BioTech & Health Care
Founded Date:
2017-01-01
Headquarters:
Barcelona, Catalonia, Spain
Number Of Exists:
1-10
Last Funding Date:
2018
Last Funding Type:
Grant
Investor Type:
For Profit
Funding Status:
Seed